Skip to Content


In the US, Nateglinide (nateglinide systemic) is a member of the drug class meglitinides and is used to treat Diabetes, Type 2.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category

Oral antidiabetic agent: Meglitinide (glinide)

Chemical Names

(-)-N-[(trans-4-isopropylcyclohexyl)carbonyl]-D-phenylalanine (WHO)

D-Phenylalanine, N-((4-(1-metyletyl)cyclohexyl)carbonyl)-, trans-

Foreign Names

  • Nateglinidum (Latin)
  • Nateglinid (German)
  • Natéglinide (French)
  • Nateglinida (Spanish)

Generic Names

  • Nateglinide (OS: USAN, BAN, JAN)
  • Natéglinide (OS: DCF)
  • A 4166 (IS)
  • AY 4166 (IS: Ajinomoto)
  • DJN 608 (IS)
  • Meglitinide (IS)
  • SDZ DJN 608 (IS: Sandoz)
  • Senaglinide (IS)
  • YM 026 (IS: Yamanouchi)
  • Nataglinide (PH: Ph. Eur. 8)
  • Nateglinid (PH: Ph. Eur. 8)
  • Nateglinide (PH: BP 2016, JP XVI, USP 38)
  • Natéglinide (PH: Ph. Eur. 8)
  • Nateglinidum (PH: Ph. Eur. 8)

Brand Names

  • Antangping
    The United Laboratories Ltd, China
  • Bei Jia
    Chia Tai Tianqing, China
  • Cankexin
    HuaXia Pharm Group, China
  • Changtai
    Xingan Pharmaceutical, China
  • Danping (pediatric)
    Wuhan, China
  • Di Fang
    Topfond Pharmaceutical, China
  • Fastic
    Ajinomoto Seiyaku, Japan
  • Fei Ge Na
    Qilu, China
  • Fu Ge Qing
    Hailing, China
  • Glinate
    Glenmark, India
  • Glinate-MF (Nateglinide and Metformin)
    Glenmark, India
  • Glunat
    U.C. Pharma, Taiwan
  • Incuria
    Sanovel, Turkey
  • Inglex
    Deva, Turkey
  • Kai Shu
    Jiacheng Medical Treatment Apparatus, China
  • Ke Bin
    Zhaohui, China
  • La Mu
    Southwest, China
  • Luoyu
    Luoxin Pharmacy, China
  • Naglid
    Abdi Ibrahim, Turkey
  • Natefine
    NeoCarDiabCare, India
  • Nateglinide Actavis
    Actavis, United States
  • Nateglinide Mylan
    Mylan Seiyaku, Japan
  • Nateglinide Nichi-Iko
    Nichi-Iko Pharmaceutical, Japan
  • Nateglinide Par
    Par Pharmaceutical, Inc., United States
  • Nateglinide Teva
    Taisho Yakuhin, Japan
  • Natenide
    Standard, Taiwan
  • Nds
    Emcure, India
  • Netcose
    Chen Ho, Taiwan
  • Nopik
    Square, Bangladesh
  • Qi Fu
    Hailing, China; Yangtze River Pharma, China
  • Roxiton
    Washington, Taiwan
  • Starform (Nateglinide and Metformin)
    Novartis, Brazil
  • Starlidine
    Idi, Egypt
  • Starlix
    Grupo Novartis, Spain; Novartis, Argentina; Novartis, Bangladesh; Novartis, Brazil; Novartis, Chile; Novartis, China; Novartis, Egypt; Novartis, Croatia (Hrvatska); Novartis, Hungary; Novartis, Indonesia; Novartis, Lithuania; Novartis, Oman; Novartis, Poland; Novartis, Portugal; Novartis, Sweden; Novartis, Turkey; Novartis, Taiwan; Novartis, United States; Novartis AH, South Africa; Novartis Biosciences, Peru; Novartis Europharm, Greece; Novartis Healthcare, Philippines; Novartis Pharma, Switzerland; Novartis Pharmaceuticals, Canada; Novartis Pharmaceuticals UK, United Kingdom
    Novartis Pharma, Germany
  • Starlix Combi (Nateglinide and Metformin)
    Novartis, Egypt
  • Starlix mite
    Novartis Pharma, Switzerland
  • Starnet
    Genovate, Taiwan
  • Starsis
    Astellas, Japan
  • Tang Ling
    Zhijun, China
  • Tang Na
    Zhongyi Pharmaceutical, China
  • Tang Rui
    Deyuan Pharmaceutical, China
  • Tang Yi
    Global Pharmaceutical, China
  • Teglix
    Biofarma, Turkey
  • Trazec
    Novartis, Portugal
  • Wan Su Xin
    Wanbang Biochemical Pharmaceutical Company, China
  • Xi Rui
    Ruinian Qianjin Pharmaceutical, China
  • Ya Li Ding
    Yabang Pharmaceutical, China
  • Yi Ke Xian
    Shihuida Group, China
  • Yi Ke Ya Xin
    Chongqing Kang er Wei Pharmaceutical Co. Ltd, China
  • Yi You Li An
    Beijing DongFang XieHe Medical Biotechnology Co., Ltd, China


BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.